Tenax Therapeutics Inc. (TENX)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
15. 85
+0.77
+5.1061%
$
267.59M Market Cap
- P/E Ratio
- Div Yield
808,300 Volume
-7.42 Eps
$ 15.08
Previous Close 
Want to track TENX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Tenax Therapeutics Inc. (TENX) Statistics
Valuation metrics
Market Cap 267.59M
Enterprise value 153.83M
Trailing P/E (ttm) -11.24
Forward P/E -
PEG ratio 3.76
Price/Sales (ttm) -
Price/Book (mrq) 6.25
Enterprise Value/Revenue -
Enterprise Value/EBITDA -2.66
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 808.28K
Average volume (90 days) 840.9K
Price summary
52-Week low 5.77
52-Week high 19.4
Beta -
50-Day moving average 13.06
200-Day moving average 13.42
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:80
Last split Date 3 Jan 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.47%
Return on equity -0.56%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.28
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.63
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 14.52%
Book value per share (mrq) 2.54
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
